Zobrazeno 1 - 4
of 4
pro vyhledávání: '"L T, Heffner"'
Autor:
S M, Devine, R B, Geller, L B, Lin, S P, Dix, H K, Holland, D, Maurer, K, O'Toole, J, Keller, D G, Connaghan, L T, Heffner, C D, Hillyer, G E, Rodey, E F, Winton, R M, Maher, W E, Fitzsimmons, J R, Wingard
Publikováno v:
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 3(1)
Initial studies of FK506 combined with methotrexate (MTX) in patients receiving unrelated donor BMT have demonstrated a possible-decrease in the incidence of severe GVHD but high rates of severe stomatitis and nephrotoxicity. With this background, we
Autor:
S P, Dix, J R, Wingard, R E, Mullins, I, Jerkunica, T G, Davidson, C E, Gilmore, R C, York, L S, Lin, S M, Devine, R B, Geller, L T, Heffner, C D, Hillyer, H K, Holland, E F, Winton, R, Saral
Publikováno v:
Bone marrow transplantation. 17(2)
Busulfan pharmacokinetics, specifically area under the concentration curve (AUC), have been correlated with the occurrence of veno-occlusive disease (VOD) following BMT. To evaluate the risk of VOD, we studied 66 patients who received pharmacotherape
Autor:
W R, Vogler, E F, Winton, L T, Heffner, D S, Gordon, P, Sternberg, I, Crocker, R, Reynolds, C K, Dobbs
Publikováno v:
Bone marrow transplantation. 6(6)
Cytosine arabinoside, 3 g/m2, every 12 h for 6 days, followed by fractionated total body irradiation, 200 cGy twice daily for 3 days, was administered to 39 adult patients undergoing bone marrow transplantation. Allogeneic transplant patients receive
Publikováno v:
Cancer. 56(5)
Three patients initially diagnosed with Hodgkin's disease developed non-Hodgkin's lymphoma 1.5, 7, and 16 years later, respectively. Combined modality therapy had been employed in one patient; the other two had received combination chemotherapy. All